{"id":29084,"date":"2025-12-25T19:18:41","date_gmt":"2025-12-25T23:18:41","guid":{"rendered":"https:\/\/www.red94.net\/news\/new-china-investors-are-dumping-industrial-stocks-at-record-pace-heres-where-the-money-is-flooding-instead\/"},"modified":"2025-12-25T19:18:41","modified_gmt":"2025-12-25T23:18:41","slug":"64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc","status":"publish","type":"post","link":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/","title":{"rendered":"New China investors are dumping industrial stocks at record pace\u2014here’s where the money is flooding instead"},"content":{"rendered":"

Chinese investors are making a dramatic strategic pivot away from legacy industrial sectors<\/b> toward high-growth opportunities in artificial intelligence and biotech<\/b>. This fundamental shift in capital allocation signals China’s transformation from a manufacturing-focused economy into a global innovation powerhouse. Here’s what’s driving this historic reallocation and why it matters for global markets.<\/p>\n

\n

\ud83d\udd25 Quick Facts<\/h3>\n
    \n
  • Hang Seng Biotech Index<\/b> gained 104.6% through September 2025, outpacing traditional sectors<\/li>\n
  • China accounts for 38% of global AI investment<\/b>, making it the world’s largest AI investor ahead of the US<\/li>\n
  • 23% of state-backed venture capital<\/b> now flows to AI-related firms, up from minimal allocation 2 years ago<\/li>\n
  • Manufacturing and industrial sectors recorded 4.9% growth in October 2025<\/b>, down from 6.5% in September<\/li>\n<\/ul>\n<\/div>\n

    The Biotech Boom: China’s 104% Index Surge<\/h2>\n

    The Hang Seng Biotech Index<\/b>, which tracks Hong Kong’s top 30 biotech firms, delivered stunning returns through 2025. This surge reflects investor confidence in China’s pivot toward pharmaceutical innovation and drug development. While US biotech stocks gained over 20% in 2025, Chinese biotech consistently outperformed global benchmarks.<\/p>\n

    China’s pharmaceutical sector has transformed from copycat manufacturing into a legitimate innovation hub. Goldman Sachs<\/b> reported that Chinese biopharma firms now conduct cutting-edge research across multiple drug development categories. The country is projected to account for 35% of US FDA approvals, up from just 5% currently, signaling a dramatic shift in global drug development leadership.<\/p>\n

    This isn’t speculation\u2014institutional investors across Hong Kong, Shanghai, and Shenzhen exchanges<\/b> are actively repositioning portfolios toward biotech. The investment thesis centers on aging populations, rising healthcare spending, and China’s government backing through the “Made in China 2025” policy targeting biotech as a critical development sector.<\/p>\n

    AI Investment Dominance: 38% of Global Capital<\/h2>\n

    Perhaps most striking is China’s dominance in global artificial intelligence investment<\/b>. According to recent data, China captures 38% of worldwide AI venture capital, surpassing the United States’ 33% share. This represents a fundamental rebalancing of tech investment away from Western markets.<\/p>\n

    State-backed venture capital funds<\/b> have accelerated this trend dramatically. In March 2025, China announced a new $138 billion national venture fund specifically targeting AI and emerging technologies. Within institutional portfolios, 23% of government VC funding now targets AI-related companies\u2014a massive increase reflecting strategic national priorities around technological autonomy.<\/p>\n

    Chinese chipmakers, software developers, and AI algorithm companies have become magnets for capital. MetaX Integrated Circuits<\/b> skyrocketed upon listing, while numerous AI-linked IPOs delivered eye-popping gains to early investors. Global asset managers are now actively eyeing Chinese AI firms as mainland and Hong Kong public markets absorb wave after wave of tech startups.<\/p>\n

    Industrial Stocks Under Pressure: Where Capital Is Leaving<\/h2>\n\n\n\n\n\n\n
    Sector<\/td>\nGrowth Rate<\/td>\nTrend<\/td>\n<\/tr>\n
    Manufacturing & Industrial<\/b><\/td>\n4.9% (Oct 2025)<\/td>\nDeclining<\/td>\n<\/tr>\n
    Legacy Infrastructure<\/b><\/td>\nDown YoY<\/td>\nUnderperforming<\/td>\n<\/tr>\n
    Banking Stocks<\/b><\/td>\nMixed<\/td>\nCapital rotation away<\/td>\n<\/tr>\n
    Biotech & AI<\/b><\/td>\n+100%+<\/td>\nSurging<\/td>\n<\/tr>\n<\/table>\n

    China’s manufacturing sector showed clear weakness in late 2025. Industrial production expanded 4.9% in October\u2014a significant slowdown from 6.5% in September and below economist expectations. This weakness in legacy industries reflects investors’ fundamental shift away from traditional manufacturing toward higher-growth sectors.<\/p>\n

    Banks and industrial stocks<\/b> specifically fell as institutional capital redeployed. The Shanghai Composite Index saw selective weakness in non-tech sectors, while technology and healthcare rallied. This pattern matches global investor behavior: abandoning mature, low-growth segments for innovation-driven opportunities.<\/p>\n

    China’s economic transformation is forcing this capital reallocation. Investment in traditional manufacturing, infrastructure, and property faces structural headwinds as the country matures and consumption patterns shift toward services and innovation.<\/p>\n

    Government Policy Accelerating the Shift<\/h2>\n

    This pivot didn’t happen by accident\u2014it reflects deliberate government strategy. The Chinese government has positioned biotechnology and artificial intelligence<\/b> as central pillars of national development. State enterprises have transitioned from passive asset holders to active financial agents, functioning as quasi-venture capital entities deploying capital into strategic sectors.<\/p>\n

    China’s $420 billion National Social Security Fund<\/b> is actively scoping technology-related investment opportunities in domestic equities. Pension funds, sovereign wealth vehicles, and state-backed investment corporations have all rebalanced portfolios toward AI and biotech. This creates powerful momentum pulling institutional capital into these sectors.<\/p>\n

    Regulatory reforms supporting biotech innovation\u2014including faster drug approval pathways and IP protections\u2014have improved investor risk-return profiles. China’s emergence as a legitimate pharmaceutical innovator requires sustained capital investment, and these policy changes ensure the investment environment remains attractive.<\/p>\n

    What This Capital Shift Means for Global Markets and Investors?<\/h2>\n

    The strategic reallocation of Chinese investor capital carries profound implications. First, it signals genuine confidence in China’s ability to lead in AI and biotech\u2014not just participate. Second, it reflects realistic assessments of legacy sectors’ growth prospects. Third, it demonstrates capital markets responding to structural economic change.<\/p>\n

    Global investors should monitor several trends ahead: continued strength in Chinese biotech and AI IPOs, potential consolidation opportunities in traditional manufacturing, and broader Asian market rotation effects. US and European tech companies may face intensified competition from well-capitalized Chinese rivals. Meanwhile, biotech licensing deals<\/b> between Chinese and Western firms will likely accelerate as China proves its innovation credentials.<\/p>\n

    The pivot also signals opportunity. While some investors abandoned Chinese stocks due to geopolitical concerns, patient capital recognizing real innovation metrics in biotech and AI could find attractive entry points. The next 5-10 years will determine whether this Chinese investment pivot produces genuine global breakthroughs or follows familiar boom-bust patterns.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":23,"featured_media":29083,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"schema_org_data":"{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Place\",\"name\":\"China\",\"description\":\"country\"},{\"@type\":\"Place\",\"name\":\"United States\",\"description\":\"country\"},{\"@type\":\"Place\",\"name\":\"Hong Kong\",\"description\":\"city\"},{\"@type\":\"Place\",\"name\":\"Shanghai\",\"description\":\"city\"},{\"@type\":\"Place\",\"name\":\"Shenzhen\",\"description\":\"city\"}]}","_extracted_celebrities":"","_extracted_movies":"","_extracted_places":null,"_extracted_videos":"","_last_enrichment_date":"2025-12-25 19:19:11","footnotes":""},"categories":[391],"tags":[],"class_list":["post-29084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-finance","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"yoast_head":"\nNew China investors are dumping industrial stocks at record pace\u2014here's where the money is flooding instead<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New China investors are dumping industrial stocks at record pace\u2014here's where the money is flooding instead\" \/>\n<meta property=\"og:description\" content=\"…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\" \/>\n<meta property=\"og:site_name\" content=\"Red94\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-25T23:18:41+00:00\" \/>\n<meta name=\"author\" content=\"Patrick Graham\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrick Graham\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\"},\"author\":{\"name\":\"Patrick Graham\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9\"},\"headline\":\"New China investors are dumping industrial stocks at record pace\u2014here’s where the money is flooding instead\",\"datePublished\":\"2025-12-25T23:18:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\"},\"wordCount\":873,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.red94.net\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png\",\"articleSection\":[\"Business & Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\",\"url\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\",\"name\":\"New China investors are dumping industrial stocks at record pace\u2014here's where the money is flooding instead\",\"isPartOf\":{\"@id\":\"https:\/\/www.red94.net\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png\",\"datePublished\":\"2025-12-25T23:18:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage\",\"url\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png\",\"contentUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png\",\"width\":1200,\"height\":678,\"caption\":\"New China investors pivot to AI and biotech while dumping legacy industrial stocks, here's why\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.red94.net\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entertainment\",\"item\":\"https:\/\/www.red94.net\/news\/entertainment\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"New China investors are dumping industrial stocks at record pace\u2014here’s where the money is flooding instead\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.red94.net\/news\/#website\",\"url\":\"https:\/\/www.red94.net\/news\/\",\"name\":\"Red94\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.red94.net\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.red94.net\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.red94.net\/news\/#organization\",\"name\":\"Red94\",\"url\":\"https:\/\/www.red94.net\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png\",\"contentUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png\",\"width\":289,\"height\":90,\"caption\":\"Red94\"},\"image\":{\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9\",\"name\":\"Patrick Graham\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg\",\"contentUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg\",\"caption\":\"Patrick Graham\"},\"description\":\"Patrick Graham is a business and finance journalist translating Wall Street's complexities into stories that matter to everyday readers. With extensive experience in financial journalism and economic analysis, this expert journalist provides sharp insights on market trends, corporate developments, and the economic forces affecting daily life. His reporting helps readers make sense of the business world's biggest moves.\",\"url\":\"https:\/\/www.red94.net\/news\/author\/patrick-graham\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New China investors are dumping industrial stocks at record pace\u2014here's where the money is flooding instead","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/","og_locale":"en_US","og_type":"article","og_title":"New China investors are dumping industrial stocks at record pace\u2014here's where the money is flooding instead","og_description":"…","og_url":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/","og_site_name":"Red94","article_published_time":"2025-12-25T23:18:41+00:00","author":"Patrick Graham","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrick Graham","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#article","isPartOf":{"@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/"},"author":{"name":"Patrick Graham","@id":"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9"},"headline":"New China investors are dumping industrial stocks at record pace\u2014here’s where the money is flooding instead","datePublished":"2025-12-25T23:18:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/"},"wordCount":873,"commentCount":0,"publisher":{"@id":"https:\/\/www.red94.net\/news\/#organization"},"image":{"@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png","articleSection":["Business & Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/","url":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/","name":"New China investors are dumping industrial stocks at record pace\u2014here's where the money is flooding instead","isPartOf":{"@id":"https:\/\/www.red94.net\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage"},"image":{"@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png","datePublished":"2025-12-25T23:18:41+00:00","breadcrumb":{"@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#primaryimage","url":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png","contentUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/41688-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc.jpg-scaled.png","width":1200,"height":678,"caption":"New China investors pivot to AI and biotech while dumping legacy industrial stocks, here's why"},{"@type":"BreadcrumbList","@id":"https:\/\/www.red94.net\/news\/64284-new-china-investors-pivot-to-ai-and-biotech-while-dumping-legacy-industrial-stoc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.red94.net\/news\/"},{"@type":"ListItem","position":2,"name":"Entertainment","item":"https:\/\/www.red94.net\/news\/entertainment\/"},{"@type":"ListItem","position":3,"name":"New China investors are dumping industrial stocks at record pace\u2014here’s where the money is flooding instead"}]},{"@type":"WebSite","@id":"https:\/\/www.red94.net\/news\/#website","url":"https:\/\/www.red94.net\/news\/","name":"Red94","description":"","publisher":{"@id":"https:\/\/www.red94.net\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.red94.net\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.red94.net\/news\/#organization","name":"Red94","url":"https:\/\/www.red94.net\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png","contentUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png","width":289,"height":90,"caption":"Red94"},"image":{"@id":"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9","name":"Patrick Graham","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.red94.net\/news\/#\/schema\/person\/image\/","url":"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg","contentUrl":"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg","caption":"Patrick Graham"},"description":"Patrick Graham is a business and finance journalist translating Wall Street's complexities into stories that matter to everyday readers. With extensive experience in financial journalism and economic analysis, this expert journalist provides sharp insights on market trends, corporate developments, and the economic forces affecting daily life. His reporting helps readers make sense of the business world's biggest moves.","url":"https:\/\/www.red94.net\/news\/author\/patrick-graham\/"}]}},"views":30,"_links":{"self":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/posts\/29084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/comments?post=29084"}],"version-history":[{"count":0,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/posts\/29084\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/media\/29083"}],"wp:attachment":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/media?parent=29084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/categories?post=29084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/tags?post=29084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}